— Know what they know.
Not Investment Advice

SPPH OTC

Spencer Pharmaceutical Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 59 · $29436 mcap

Cash Flow Trends

Operating Cash Flow
-$770K +71.1% ▲
Capital Expenditures
$0 +100.0% ▲
Free Cash Flow
-$770K +71.3% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$283K +76.0% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2001FY2002FY2003
— Operating Activities —
Net Income-$2M-$2M-$863K
Depreciation & Amort.$1M$49K$0
Stock-Based Comp.$0$0$0
Change in Working Capital$1M-$471K$93K
Other Non-Cash Items$0$0$0
Operating Cash Flow$146K-$3M-$770K
— Investing Activities —
Capital Expenditures-$31K-$16K$0
Acquisitions (Net)$0$0$0
Investment Purchases$0$0$0
Investment Sales$0$0$0
Other Investing-$6K$0-$1M
Investing Cash Flow-$38K-$16K-$1M
— Financing Activities —
Net Debt Issuance-$187K$0$154K
Stock Repurchased$0$0$0
Dividends Paid$0$0$0
Other Financing$0$0$0
Financing Cash Flow$1M$2M$2M
Net Change in Cash$1M-$1M-$283K
Cash End of Period$1M$304K$21K
Free Cash Flow$114K-$3M-$770K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms